Professor, Behavioural and Social Sciences and Internal Medicine, Brown University School of Public Health and Alpert School of Medicine
Dr. Ahluwalia is a physician and public health scientist at Brown University’s Schools of Public Health and Medicine. He has been in academic medicine since 1992 and has been a practicing physician, faculty member, department chair, Associate Dean and Center Director in medical schools, and School of Public Health Dean. His primary research areas are health disparities and smoking cessation and nicotine addiction in African-American smokers. He has been continuously funded by NIH for 25 years and has published more than 300 manuscripts. Ahluwalia has served on the U.S. government’s National Advisory Council on Minority Health and Health Disparities, on the SRNT Board of Directors, and is currently appointed to the Interagency Committee on Smoking and Health chaired by the US Surgeon General. Dr. Ahluwalia trained at NYU, received a MD and MPH at Tulane University, a Medicine residency at UNC Chapel Hill, and a clinical epidemiology fellowship at Harvard Medical School, where he received a masters degree in health policy.
Chief Executive, Action on Smoking and Health (ASH)
Deborah Arnott is a recognised international expert on tobacco control and the WHO Framework Convention on Tobacco Control, with a particular interest in nicotine regulation and harm reduction. She was a member of the NICE Programme Development Group which developed the guidance on tobacco harm reduction and of the Commission on Human Medicines expert advisory group to the MHRA on nicotine containing products. She also has experience of product regulation under the EU General Product Safety Directive having participated in the development of fire safety requirements for cigarettes.
Deborah has an MBA from Cranfield, is an honorary Associate Professor at the University of Nottingham, and a member of the Royal College of Physicians Tobacco Advisory Group. She was awarded the Alwyn Smith prize in 2007 by the Faculty of Public Health for her outstanding contribution to public health.
Competing Interest: None Stated
Director, Counterfactual Consulting Ltd
Clive Bates has had a diverse career in the public, private and not-for-profit sectors. He started out with the IT company, IBM, then switched career to work in the environment movement. From 1997-2003 he was Director of Action on Smoking and Health (UK), campaigning to reduce the harms caused by tobacco. In 2003 he joined Prime Minister Blair’s Strategy Unit as a civil servant and worked in senior roles in the public sector and for the United Nations in Sudan. He is now Director of Counterfactual, a consulting and advocacy practice focussed on a pragmatic approach to sustainability and public health.
Team Leader - Tobacco Control, Alcohol and Gambling Policy Lead, Department of Health and Social Care
Matthew has worked at the Department of Health for over nineteen years in a wide range of health and care policy areas, working and collaborating with a variety of stakeholders, including at an international level.
He currently works as a Team Leader on tobacco control covering legislation and policy areas on novel tobacco products, e-cigarettes, and is also the UK FCTC focal point. He is also currently overseeing a 5 year UK ODA funded FCTC 2030 project, being led by the FCTC secretariat to improve tobacco control in low and middle income countries. In addition to tobacco policy Matthew also covers various areas of alcohol and gambling health harms policy for the Department.
Matthew completed a Masters in Health Policy at Imperial College London in November 2015. Matthew is married and has a young son and all live in the beautiful city of Leeds.
Professor of Psychology - Health Behaviour, University of Melbourne, Australia
Ron Borland PhD is a Professor of Psychology-Health Behaviour at the University of Melbourne since mid 2019. Prior to that he was the Nigel Gray Distinguished Fellow in Cancer Prevention, at The Cancer Council Victoria, Australia where he worked for 33 years. He has published over 400 peer-reviewed papers. He is listed in the Web of Science list of the World’s most influential scientists. He is one of the Principal Investigators of the International Tobacco Control Policy Evaluation Project: an international collaboration that is analysing the impact of policies on smoking. He has a special interest in harm minimisation strategies and strategies to assist highly disadvantaged, high risk prevalence groups. He takes a systems approach to theorising that integrates individual level and population level change. He is the author of CEOS theory: a comprehensive theory of Hard to Maintain Behaviour Change.
Professor of Epidemiology, Diretor UK Centre for Tobacco & Alcohol Studies, University of Nottingham
John Britton is professor of epidemiology at the University of Nottingham and a consultant in respiratory medicine at Nottingham City Hospital. He is director of the UK Centre for Tobacco and Alcohol Studies, a member of the Royal College of Physicians Tobacco Advisory Group, and of the board of trustees of Action on Smoking and Health.
Tobacco Control Programme Lead, Publich Health England
Martin is Tobacco Control Programme Lead for Public Health England. He joined PHE in February after 7 years at Action on Smoking and Health. Martin has worked in Public Health since the mid 1980’s when he was involved in HIV prevention work. He is a fellow of the Royal Society of Public Health.
Director, Center for Tobacco Control, American Cancer Society, Vice President, Tobacco Control
Cliff Douglas, an internationally recognized expert in tobacco control policy and law, is American Cancer Society Vice President for Tobacco Control and Director of the American Cancer Society Center for Tobacco Control. Previously, Douglas oversaw the University of Michigan Tobacco Research Network, an association of faculty members, researchers, and staff committed to tobacco and nicotine research and service. As a faculty member at the University of Michigan School of Public Health, Douglas taught a graduate tobacco control policy seminar for ten years.
Douglas has served as the consulting tobacco control policy advisor for the U.S. Assistant Secretary for Health, Dr. Howard Koh, in which capacity Douglas co-authored the U.S. Department of Health and Human Services’ national tobacco control strategic action plan, Ending the Tobacco Epidemic: A Tobacco Control Strategic Action Plan for the U.S. Department of Health and Human Services, released by U.S. Secretary of Health Kathleen Sebelius in 2011. Douglas also served as special counsel for Congressman Martin Meehan (D-MA) and the Congressional Task Force on Tobacco and Health in the U.S. House of Representatives. He is a graduate of the University of Michigan and the University of Michigan Law School.
Professor of Public Health, Faculty of Medicine, University of Geneva, Switzerland
Jean-François Etter completed master’s degrees in public health and in political science, and a doctorate in economics and social sciences at the University of Geneva. He joined the Faculty of Medicine in 1992, where he became associate professor in 2012 and full professor in 2019. His research focuses on the prevention of smoking and the treatment of tobacco addiction. He is particularly interested in new technologies that vaporize nicotine and tobacco, new ways of using nicotine replacement therapy, and the use of new information technologies to help smokers quit.
Research Fellow, Onassis Cardiac Surgery Greece, Department of Pharmacology, University of Patras, Greece
Konstantinos Farsalinos, MD, MPH is a cardiologist and research fellow at the Onassis Cardiac Surgery Center in Athens-Greece, at the Department of Pharmacy, University of Patras-Greece and at the National School of Public Health-Greece. He is specialized in echocardiography and in smoking and tobacco harm reduction research. He has received a scholarship from the Greek Society of Cardiology and performed research on cardiovascular imaging in Catholic University of Leuven, Belgium. He was the lead researcher in Intervendor Study, a joint research project of the European and American Societies of Echocardiography. He has been conducting laboratory, clinical and epidemiological research on smoking, tobacco harm reduction and e-cigarettes as principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. He has analyzed patterns of e-cigarette use based on large European and US population surveys (Eurobarometer, National Youth Tobacco Survey, National Health Interview Survey, Behavioral Risk Factor Surveillance System). He also co-authored the first systematic review on e-cigarette safety, published in 2014. Additionally, he is performing research work on heated tobacco products. His research findings have been presented in major international scientific congresses and his studies were used in preparing the regulatory framework on e-cigarettes by the European Union. As of early 2019, he has published more than 75 studies in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes. He was the handling editor and author in a book titled “Analytical assessment of e-cigarettes”, published by Elsevier in 2017.
Competing Interest: For some of the studies, the institution has received funding from e-cigarette companies. None of the researchers received any compensation for participating to the studies.
Professor of Clinical Psychology, Queen Mary University of London
Peter Hajek is Professor of Clinical Psychology and Director of the Tobacco Dependence Research Unit at the Wolfson Institute of Preventive Medicine, Queen Mary University of London. His research is concerned primarily with understanding health behaviours, and developing and evaluating both behavioural and pharmacological treatments for dependent smokers and for people with weight problems. Professor Hajek is a member of a number of expert groups, advisory bodies and editorial boards, and has authored or co-authored over 350 publications.
Technical Director, Totally Wicked Ltd
Liam is a technologist, engineer and scientist committed to the ongoing development of the e-cigarette, e-liquids and vaping in the interest of providing a continuously improving alternative to combustible tobacco. He was steering group member for one of the first recognised standards concerning e-cigarettes, BSI PAS 54115:2015. Since then he has been active in European Standards development through CEN TC 437, including the publication of the first European standards publication on e-cigarette devices, CEN TS 17287:2019. In his role at Totally Wicked he has been involved in the design, development and manufacture of vaping devices since 2011, and in e-liquid development since 2012. In his role at IBVTA he has been directly involved in dialogue with governments, regulators and enforcement agencies since 2014. A vaper of nearly 8 years, and ex-smoker for the same period, his background is in race car engine development, engineering design, academic research and university lecturing.
Senior Research Fellow, Dep't of Behavioural Science & Health, University College London
Sarah is a Senior Research Fellow in the Tobacco and Alcohol Research Group within the Department of Behavioural Science and Health at University College London. Her research focuses on individual- and population-level influences on cigarette smoking and quitting activity, with a focus on the role played by e-cigarettes. She is Associate Editor at the journal Addiction and member of ASH’s advisory council of tobacco control experts.
Emeritus Professor of Health Psychology, Dep't Behavioural Science & Health, University College London
Martin Jarvis is Emeritus Professor of Health Psychology at the Department of Behavioural Science & Health, University College London. He has been researching tobacco and nicotine use for the past 40 years, He has served as a trustee of ASH, was Chair of the UK government’s Technical Advisory Group on Tobacco and Health, and was Specialist Adviser to the House of Commons Health Committee’s inquiries into tobacco and health and into smoking in public places. He was for some years a member of the World Health Organisation’s study group on Tobacco Product Regulation.
With colleagues Robert West and Jamie Brown he has recently published a paper on the youth vaping “epidemic” in the USA :
Jarvis MJ, West R, Brown J. Epidemic of youth nicotine addiction? What does the National Youth Tobacco Survey reveal about high school e-cigarette use in the USA?
Independent Consultant in Public Health and Tobacco Dependence, Scientist, Smoking Cessation Specialist, Trainer, Rennes, France
Dr Jacques Le Houezec, trained as a neuroscientist in Paris, and Clinical pharmacology in San Francisco, has been working on nicotine and smoking cessation for more than 35 years. He is a Consultant in Public Health & Tobacco dependence, based in Rennes, France. He is also Honorary Clinical Associate Professor, UK Centre for Tobacco and Alcohol Studies, School of Medicine, University of Nottingham, UK. Specialised in vaping products to help smokers quit smoking, he is now doing trainings and Certifications for vapeshops and Health professionnals.
Bruce and John Usher Professor of Public Health, The University of Edinburgh
Linda Bauld holds the Bruce and John Usher Chair in Public Health in the Usher Institute, College of Medicine at the University of Edinburgh. Linda is a behavioural scientist with a PhD in social policy whose research focuses on the primary prevention of Non Communicable Diseases (NCDs) in the UK and further afield. Since 2014, she has combined her academic role with a secondment to Cancer Research UK where she holds the CRUK/BUPA Chair in Behavioural Research for Cancer Prevention. She currently leads two large research consortia – the GCRF Tobacco Control Capacity Programme in Africa and South Asia, supported by UK Research and Innovation via Overseas Development Aid funding, and the SPECTRUM Consortium, involving teams in 10 UK Universities and partner organisations funded by the UK Prevention Research Partnership. SPECTRUM is the successor to the UK Centre for Tobacco and Alcohol Studies. Linda is a Fellow of the Royal College of Physicians of Edinburgh, the Royal Society of Edinburgh and the Academy of Social Sciences, and currently chairs or is a member of research funding and policy committees for CRUK, National Institute for Health Research, the Medical Research Council, International Agency for Research on Cancer, Public Health England, Institute for Alcohol Studies, the Scottish Government and Health Canada.
Professor of Tobacco Addiction, UK Centre for Tobacco and Alcohol Studies (UKCTAS), Kings College London
Ann McNeill is Professor of Tobacco Addiction in the National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience. She carried out her PhD at the then Institute of Psychiatry focusing on the development of dependence on smoking. Since that time she has held a variety of academic and public sector posts focusing largely on tobacco control research. Ann has an established international reputation, receiving a World Health Organisation award for contributions to tobacco control in 1998. She has published more than 250 academic papers book chapters, reports and opinion pieces on the subject and her research ranges across prevention, cessation, harm reduction and local, national and international policy. Ann is a Deputy Director of the UK Centre for Tobacco and Alcohol Studies.
Competing Interest: None Stated
Reader, School of Social Sciences and Health & Deputy Director DECIPHer, Cardiff University
Graham Moore is a Reader in Social Sciences and Health and Deputy Director of the DECIPHer research centre in Cardiff University. His main interest are in child and adolescent health inequalities. As a major contributor to the intergenerational reproduction of inequalities, he has a keen interest in tobacco control. He has led a number of studies on children and adolescents’ exposure to secondhand smoke and perceptions of tobacco and e-cigarettes.
Founder and Former Executive Director, Drug Policy Alliance
Ethan has played a leading role in harm reduction and other drug policy reform efforts in the United States and globally since the late 1980s. He was born in New York City, received his BA, JD, and PhD from Harvard, and taught politics and public affairs at Princeton University (1987-1994). He then founded first The Lindesmith Center (1994-2000, a drug policy institute created with the philanthropic support of George Soros) and then the Drug Policy Alliance (DPA), which he directed from 2000 until 2017. His TED Talk, “Why we need to end the drug war,” has almost two million views.
Director of Health Improvement, Public Health England
Professor John Newton is the Chief Knowledge Officer of Public Health England and joining PHE having been the Regional Director of Public Health for NHS South Central since 2007 and Honorary Professor of Public Health and Epidemiology at the University of Manchester since 2004. He has twenty years of experience as a consultant in public health with a strong track record in academic, professional service and senior management roles. As well as being and academic epidemiologist in the University of Oxford for eleven years, he has also been Director of Research and Development in two large NHS teaching hospitals (Southampton and Oxford) and was the first Director and CEO of IK Biobank. He has a long-standing interest in the use of knowledge to drive public health practice. In 2005 he led work for the Department of Health on a national public health information and intelligence strategy and has recently been centrally involved in managing the information and intelligence function for Public Health England.
Senior Lecturer in Mental Health, Addiction Research Group Lead, Medical School, University of East Anglia
Dr Caitlin Notley is a Senior Lecturer in Mental Health and lead of the Addiction Research group within the Medical School at the University of East Anglia. She has over 15 years experience leading research in addictions, in recent years focused on smoking relapse prevention, with a particular interest in vulnerable populations, postpartum relapse, and harm reduction approaches, including vaping. She led the Cancer Research UK funded ‘Electronic Cigarette Trajectories’ project, using longitudinal mixed methods data to understand user perspectives of switching from smoking to vaping, patterns of use, and social, identity related and cultural factors that may impact on long term tobacco smoking abstinence. Currently she is working with vape shops to develop relapse prevention interventions and leads a programme of research within NHS settings supporting women who stopped smoking during pregnancy to stay stopped.
Visiting Professor, Lee Kuan Yew School of Public Policy, National University of Singapore
Professor Tikki Pang is presently Visiting Professor, Lee Kuan Yew School of Public Policy, National University of Singapore. He was previously Director, Research Policy & Cooperation, World Health Organization (WHO), Geneva, Switzerland (1999-2012). Prior to joining WHO, he was Professor of Biomedical Sciences, Institute of Postgraduate Studies & Research, University of Malaya, Kuala Lumpur, Malaysia (1989-1999) and Lecturer/Associate Professor, Dept of Microbiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia (1977-1989). He was Co-Director of the WHO Collaborating Centre for Dengue & Dengue Haemorrhagic Fever at the University of Malaya, Kuala Lumpur, Malaysia (1982-1995), and a member of the WHO Technical Advisory Group which developed the guideline Dengue Haemorrhagic Fever: Diagnosis, Treatment and Control (1986). He holds a PhD in Immunology-Microbiology from the Australian National University, Canberra, Australia and is a Fellow of the Royal College of Pathologists (UK), Institute of Biology (UK), American Academy of Microbiology (USA), Academy of Medicine of Malaysia, and Academy of Sciences for the Developing World (TWAS). He has published >250 scientific articles and 12 books and was lead author on several major WHO reports including the World Health Report 2013: Research for Universal Health Coverage (2013), Knowledge for Better Health (2004) and Genomics and World Health (2002). His research interests are in epidemiology, pathogenesis, laboratory diagnosis and prevention of infectious diseases, biosecurity and dual-use research, genomics & global health, and in health research policy, health research systems, global health governance, best practices in research, development of research capabilities in developing countries, and linkages between research and policy.
Managing Director, ECigIntelligence
The founder and managing director of ECigIntelligence, Tim is a UK-qualified attorney, having worked at the European Commission, BSkyB and Herbert Smith (an international law firm), AOL Europe, as director of public affairs at Betfair (IPO in 2010 valued at £1.5bn), and as a partner in a New York VC-funded start-up in the diamond sector. Tim holds a Postgraduate Diploma in Legal Practice from the University of Law, London and a Masters in Geology from Oxford University.
Senior Post Doctoral Researcher in Tobacco Addiction, Kings College London
Debbie Robson, RMN, PhD
Senior Post Doc Researcher, Addictions Department, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK
Debbie is part of the Nicotine Research Group in the National Addiction Centre, King’s College London and has over 30 years clinical, education and research experience in the field of mental health. Her current role involves the development, implementation and evaluation of tobacco dependence treatment initiatives for people with mental health and/ or substance use problems who smoke. Debbie is part of the NIHR Applied Research Care (ARC) South London team where she leads a programme of research about tobacco dependence and treatment across several acute and mental health hospitals. She is also part of SPECTRUM, a MRC funded consortium that is investigating the commercial determinants of health and health inequalities. Debbie is a co-author of Public Health England commissioned e-cigarette evidence reviews and has recently become a Trustee of Action on Smoking and Health.
Vice Chair, NNA
Louise worked in learning disabilities for over 30 years, both in nursing and managing a care home, before taking on a second career in tobacco control/smoking cessation in 2004. Excited by the potential of vaping to accelerate quit rates, she coined the phrase ‘ecig-friendly stop smoking service’ and has worked ever since to encourage other services, commissioners and healthcare workers to adopt this approach.
She retired in March 2018 and now works as a freelance clinical consultant for the National Centre for Smoking Cessation and Training.
Professor of Health Psychology, Dep't of Behavioural Science and Health,UCL
Robert West is Professor of Health Psychology at University College London, UK. He is Editor-in-Chief of the journal Addiction. He specialises in addiction and behaviour change. He has authored or co-authored more than 900 scientific works including several books: Energise: The Secrets of Motivation, Theory of Addiction, Models of Addiction, The SmokeFree Formula, and The Behaviour Change Wheel. His personal website is www.rjwest.co.uk. Twitter: @robertjwest.
He has undertaken research and consultancy for companies that develop and manufacture smoking cessation medications but not e-cigarettes. He is an unpaid advisor to the UK’s National Centre for Smoking Cessation and Training. Most of his research is funded by Cancer Research UK.